FluidCrystal® extended release formulation of zilucoplan achieved rapid and sustained pharmacodynamic inhibition of complement C5 in non-human primates, supporting at least once weekly dosing
PR Newswire
CAMBRIDGE, Massachusetts and LUND, Sweden, July 16, 2019